- Rating
- 2
- Confidence
- 3
- Informativeness
- 2
- Presentation
- 3
- Soundness
- 2
Read review
Paper summary
StructAlign uses cohort-level pathway statistics to guide multimodal cancer survival prediction from histopathology and genomic data. CPA aligns similarities among patient-specific pathway representations with population-level pathway correlations, while PSA guides pathway attention using survival associations. Experiments across six cancer cohorts support the method’s predictive effectiveness and the contribution of both regularizers.
Critical strengths
S1. Clear rationale and complementary regularization objectives.
CPA constrains relationships between pathway representations, while PSA guides pathway aggregation. This provides a coherent and plausible approach to incorporating cohort-level statistical knowledge into patient-specific multimodal learning. The formulation is clear, and the paper specifies that the guidance is computed exclusively from training data.
S2. Empirical support for predictive effectiveness.
The comparative experiments support improved survival prediction, and the component ablations support a useful contribution from each regularizer within the proposed architecture. Together, these findings support the method’s empirical value.
Critical weaknesses
W1. Missing comparisons of structural and attention properties with and without regularization.
The ablation study evaluates predictive performance, whereas the structural and attention analyses are reported only for the full model. Consequently, the experiments do not establish how much CPA and PSA change these properties, or whether such changes accompany predictive improvements. In particular, the model without either regularizer may already exhibit some structural consistency or survival-associated attention preferences. Demonstrating these properties in the full model alone does not establish their incremental improvement due to the proposed regularizers. This limits the evidence supporting the paper’s structural alignment contribution.
W2. Qualitative evidence does not quantify the strength or consistency of the claimed properties across patients.
The paper computes similarity matrices for individual patients and then averages them for visualization. However, it does not report patient-level alignment errors or their distribution. Similarity between the average matrix and the target can conceal substantial variation across patients. Likewise, the attention analysis visualizes pathway preferences for uncensored patients ordered by observed event time, but does not quantify the strength or uncertainty of the attention–survival association. These visualizations provide suggestive evidence, but are insufficient to assess the magnitude and consistency of the claimed properties across patients.
Questions for authors
- On the same held-out patients, how do the four configurations—neither regularizer, CPA only, PSA only, and both—compare in structural consistency and survival-associated attention preferences? To what extent does the model without either regularizer already exhibit these properties?
- Could the authors report patient-level structural alignment error distributions and quantitative measures of the attention–survival association, and clarify whether these analyses use training, validation, or test patients?
- Across cohorts and cross-validation folds, do improvements in these properties accompany improvements in C-index? Are there cases where prediction improves without a corresponding improvement in structural alignment or attention preferences?